Lack of expression of an alternative CD20 transcript variant in circulating B cells from patients with pemphigus

Experimental Dermatology

Volumn 23, Issue 1, 2014, Pages 66-67

  Gamonet, Clémentine ^a   Ferrand, Christophe ^a   Colliou, Natacha ^b   Musette, Philippe ^b   Joly, Pascal ^b   Girardin, Marie ^c   Humbert, Philippe ^c   Aubin, François ^c  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

^c UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

CD20; Pemphigus; Rituximab

Indexed keywords

AZATHIOPRINE; CD20 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN; IMMUNOGLOBULIN; MESSENGER RNA; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POKEWEED MITOGEN; RITUXIMAB; STEROID;

ANTIGEN EXPRESSION; ANTIGENIC VARIATION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BULLOUS PEMPHIGOID; CLINICAL ARTICLE; FLOW CYTOMETER; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LETTER; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROID THERAPY;

CD20; PEMPHIGUS; RITUXIMAB;

AGED; ALTERNATIVE SPLICING; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; B-LYMPHOCYTES; FEMALE; GENETIC MARKERS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PEMPHIGUS; RNA, MESSENGER;

EID: 84891356506     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12299     Document Type: Letter

References (5)

1. España A, Mòdol T, Gil M P et al. Exp Dermatol 2013: 22: 125-130.
2. Joly P, Mouquet H, Roujeau J C et al. N Engl J Med 2007: 357: 545-552.
3. Schmidt E, Goebeler M, Zillikens D. Ann N Y Acad Sci 2010: 1173: 683-691.
4. Henry C, Deschamps M, Rohrlich P S et al. Blood 2010: 115: 2420-2429.
5. Ferrand C, Robinet E, Contassot E et al. Hum Gene Ther 2000: 11: 1151-1164.